Members

Oncodrex

Oncodrex’s discovery of unique molecular signatures of metastatic cancers allows the Company to develop targeted therapeutics for those cancers, as well as companion diagnostics to identify patients who will respond to the therapeutics. Combined, this provides a significant differentiator from the current standard of care.

Contact Info

23 Edington Point Winnipeg R3Y 0A2 MB Canada
P: 1 204 416 8256
F: 1 204 416 8256
W: oncodrex.com

member

Back

Latest News

PhD in pharmacology helps grad thrive in business

November 22, 2023

Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.

Solnul: Scientific advances + international approvals prime prebiotic to ‘become a global household name’

November 16, 2023

With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate

Innovate, Protect, Thrive: New ElevateIP Program Plays Crucial Role in the Success of Canadian Start-ups

November 16, 2023

ElevateIP is a program funded by the Government of Canada aimed at equipping and supporting Canadian start-ups with the tools and knowledge to understand, strategize, protect, manage and leverage their intellectual property (IP)

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.